Plasma Concentrations of Cholecystokinin and Neurotensin in Patients with Cystic Fibrosis

References

• Lebenthal E, Lerner A, Rolston DDK. The pancreas in cystic fibrosis. The pancreas: biology, pathobiology, and disease. 2nd ed, VLW Go, EP Di Magno, JD Gardner, E Lebenthal, HA Reber, GA Scheele. Raven Press, New York 1993; 1041–81
   Google Scholar
• Adler G, Beglinger C. Hormones as regulators of pancreatic secretion in man. Eur J Clin Invest 1990; 20: 827–32, Suppl 1
   Google Scholar
• Liddle RA, Goldfine ID, Rosen MS, Taplitz RA, Williams JA. Cholecystokinin bioactivity in human plasma: molecular forms, responses to feeding, and relationship to gallbladder contraction. J Clin Invest 1985; 75: 1144–52
   PubMed Web of Science ®Google Scholar
• Owyang C, May D, Louie DS. Trypsin suppression of pancreatic enzyme secretion. Differential effect on cholecystokinin release and the enteropancreatic reflex. Gastroenterology 1986; 91: 637–43
   PubMedGoogle Scholar
• Owyang C, Louie DS, Tatum D. Feedback regulation of pancreatic enzyme secretion. Suppression of cholecystokinin release by trypsin. J Clin Invest 1986; 77: 2042–7
   PubMed Web of Science ®Google Scholar
• Adler G, Reinshagen M, Koop I, Göke B, Schafmayer A, Rovati LC. Differential effects of atropine and a cholecystokinin receptor antagonist on pancreatic secretion. Gastroenterology 1989; 96: 1158–64
   PubMedGoogle Scholar
• Diugosz J, Fölsch UR, Czajkowski A, Gabryelewicz A. Feedback regulation of stimulated pancreatic enzyme secretion during intraduodenal perfusion of trypsin in man. Eur J Clin Invest 1988; 18: 267–72
   PubMedGoogle Scholar
• Mössner J, Stange JH, Ewald M, Kestel W, Fischbach W. Influence of exogenous application of pancreatic extracts on endogenous pancreatic enzyme secretion. Pancreas 1991; 6: 637–44
   PubMedGoogle Scholar
• Schmidt WE, Creutzfeldt W, Schleser A, Roy Choudhury A, Nustede R, Höcker M. Role of CCK in regulation of pancreaticobiliary functions and GI motility in humans: effects of loxiglumide. Am J Physiol 1991; 260: G197–206
   PubMedGoogle Scholar
• Adler G, Müllenhoff A, Koop I, Bozkurt T, Göke B, Beglinger C. Stimulation of pancreatic secretion in man by a protease inhibitor (camostate). Eur J Clin Invest 1988; 18: 98–104
   PubMed Web of Science ®Google Scholar
• Ferris CF, George JK, Eastwood G, Potegal M, Carraway RE. Plasma levels of human neurotensin: methodological and physiological considerations. Peptides 1991; 12: 215–20
   PubMedGoogle Scholar
• Blackburn AM, Bloom SR, Long RG, Fletcher DR, Christofides ND, Fitzpatrick ML. Effect of neurotensin on gastric function in man. Lancet 1980; 1: 987–89
   PubMed Web of Science ®Google Scholar
• Skov Olsen P, Holst Pedersen J, Kirkegaard P, Stadil F, Fahrenkrug J, Christiansen J. Neurotensin inhibits mealstimulated gastric acid secretion in man. Scand J Gastroenterol 1983; 18: 1073–6
   PubMed Web of Science ®Google Scholar
• Thor K, Rosell S, Rökaeus A, Kager L. (Gln4)-Neurotensin changes the motility pattern of the duodenum and proximal jejunum from a fasting-type to a fed-type. Gastroenterology 1982; 83: 569–74
   PubMed Web of Science ®Google Scholar
• Schafmayer A, Werner M, Becker HD. Radioimmunological determination of cholecystokinin in tissue extracts. Digestion 1982; 24: 146–54
   PubMed Web of Science ®Google Scholar
• Nustede R, Köhler H, Pfannkuche A, Fölsch UR, Schafmayer A. The biological relevance of N-terminal neurotensin fragments in the regulation of exocrine pancreas secretion. Pancreas 1989; 4: 114–9
   PubMedGoogle Scholar
• Schafmayer A, Becker HD, Werner M, Fölsch UR, Creutzfeldt W. Plasma cholecystokinin levels in patients with chronic pancreatitis. Digestion 1985; 32: 136–9
   PubMed Web of Science ®Google Scholar
• Funakoshi A, Nakano I, Shinozaki H, Tateishi K, Hamaoka T, Ibayashi H. High plasma cholecystokinin levels in patients with chronic pancreatitis having abdominal pain. Am J Gastroenterol 1986; 81: 1174–8
   PubMed Web of Science ®Google Scholar
• Gomez Cerezo J, Codoceo R, Fernandez Calle P, Molina F, Tenias JM, Vazquez JJ. Basal and postprandial cholecystokinin values in chronic pancreatitis with and without abdominal pain. Digestion 1991; 48: 134–40
   PubMedGoogle Scholar
• Nustede R, Köhler H, Fölsch UR, Schafmayer A. Plasma concentrations of neurotensin and CCK in patients with chronic pancreatitis with and without enzyme substitution. Pancreas 1991; 6: 260–5
   PubMed Web of Science ®Google Scholar
• Isaksson G, Ihse I. Pain reduction by an oral pancreatic enzyme preparation in chronic pancreatitis. Dig Dis Sci 1983; 28: 97–102
   PubMed Web of Science ®Google Scholar
• Slaff J, Jacobson D, Tillman CR, Curington C, Toskes P. Protease-specific suppression of pancreatic exocrine secretion. Gastroenterology 1984; 87: 4–52
   Google Scholar
• Slaff JI, Wolfe MM, Toskes PP. Elevated plasma cholecystokinin levels in pancreatic exocrine impairment: evidence to support feedback regulation. J Lab Clin Med 1985; 105: 282–5
   PubMed Web of Science ®Google Scholar
• Rämö OJ, Puolakkainen PA, Seppälä K, Schröder TM. Self-administration of enzyme substitution on the treatment of exocrine pancreatic insufficiency. Scand J Gastroenterol 1989; 24: 688–92
   PubMed Web of Science ®Google Scholar
• Cantor P, Petronijevic L, Worning H. Plasma cholecystokinin concentrations in patients with advanced chronic pancreatitis. Pancreas 1986; 1: 488–97
   PubMedGoogle Scholar
• Bozkurt T, Adler G, Koop I, Koop H, Türmer W, Arnold R. Plasma CCK levels in patients with pancreatic insufficiency. Dig Dis Sci 1988; 33: 276–81
   PubMed Web of Science ®Google Scholar
• Mössner J, Black T, Regner U, Fischbach W. Plasma cholecystokinin in chronic pancreatitis. Z Gastroenterol 1989; 27: 401–5
   PubMedGoogle Scholar
• Nakamura T, Takebe K, Kudoh K, Ishii M, Imamura K, Kikuchi H. No negative feedback regulation between plasma CCK levels and luminal tryptic activities in patients with pancreatic insufficiency. Int J Pancreatol 1995; 17: 29–35
   PubMedGoogle Scholar
• Nealon WH, Beauchamp RD, Townsend CM, Boyed G, Sabot M, Thompson JC. Diagnostic role of gastrointestinal hormones in patients with chronic pancreatitis. Ann Surg 1986; 204: 430–4
   PubMed Web of Science ®Google Scholar
• Bali A, Stableforth DE, Asquith P. Prolonged small intestinal transit time in cystic fibrosis. Br Med J 1983; 287: 1011–3
   PubMed Web of Science ®Google Scholar
• Murphy MS, Brunetto AL, Pearson AD, Ghatei MA, Nelson R, Eastham EJ. Gut hormones and gastrointestinal motility in children with cystic fibrosis. Dig Dis Sci 1992; 37: 187–92
   PubMedGoogle Scholar
• Robb TA, Davidson GP, Kirubakaran C. Conjugated bile acids in serum and secretions in response to cholecystokinin/secretin stimulation in children with cystic fibrosis. Gut 1985; 26: 1246–56
   PubMedGoogle Scholar
• Hayman PE. Absent postprandial duodenal motility in a child with cystic fibrosis. Gastroenterology 1986; 90: 1274–9
   PubMedGoogle Scholar
• Cavell B. Gastric emptying in infants with cystic fibrosis. Acta Pediatr Scand 1981; 70: 635–8
   PubMedGoogle Scholar
• Roulet M, Weber AM, Paradis Y, Roy CC, Chartrand L, Lasalle R. Gastric emptying and lingual lipase activity in cystic fibrosis. Pediatr Res 1980; 14: 1360–2
   PubMedGoogle Scholar
• Vantrappen GR, Peeters TL, Janssens J. The secretory component of the interdigestive migrating motor complex in man. Scand J Gastroenterol 1979; 14: 663–7
   PubMed Web of Science ®Google Scholar
• Darling P, Lepage G, Leroy C, Masson P, Roy CC. Effect of taurine supplements on fat malabsorption in cystic fibrosis. Pediatr Res 1985; 19: 578–82
   PubMedGoogle Scholar
• Colombo C, Arlati S, Curcio L, Maiavacca R, Garatti M, Ronchi M. Effect of taurine supplementation on fat and bile acid absorption in patients with cystic fibrosis. Scand J Gastroenterol 1988; 23: 151–6, Suppl 143
   PubMed Web of Science ®Google Scholar
• Ihse I, Lilja P, Lundquist I. Feedback regulation of pancreatic enzyme secretion by intestinal trypsin in man. Digestion 1977; 15: 303–8
   PubMed Web of Science ®Google Scholar
• Yasui A, Nimura Y, Hayakawa N, Hayakawa T, Shibata T, Kondo T. Feedback regulation of basal pancreatic secretion in humans. Pancreas 1988; 3: 681–7
   PubMedGoogle Scholar
• Allen JM, Penketh ARL, Adrian TE, Lee YC, Sarson DL, Hodson ME. Adult cystic fibrosis: postprandial response of gut regulatory peptides. Gastroenterology 1983; 85: 1379–83
   PubMedGoogle Scholar
• Feurle GE, Hofmann G, Carraway R, Baca I. Reproduction of postprandial neurotensin plasma levels by intravenous neurotensin and the effect of neurotensin on exocrine pancreatic secretion in humans. Pancreas 1986; 4: 329–34
   Google Scholar
• Kihl B, Rokaeus A, Rosell S, Olbe L. Fat inhibition of gastric acid secretion in man and plasma concentrations of neurotensinlike immunoreactivity. Gastroenterology 1981; 16: 513–26
   Google Scholar
• Fletcher DR, Shulkes A, Bladin PHD, Booth D, Hardy KJ. Cholinergic inhibition of meal stimulated plasma neurotensin like immunoreactivity in man. Life Sci 1983; 33: 863–9
   PubMedGoogle Scholar
• Nustede R, Schmidt WE, Köhler H, Fölsch UR, Schafmayer A. The influence of bile acids on the regulation of exocrine pancreatic secretion and on the plasma concentrations of neurotensin and CCK in dogs. Int J Pancreatol 1993; 13: 23–30
   PubMedGoogle Scholar